phosphoserine has been researched along with beryllium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdul, AR; Gary, RK; Gorjala, P; Mudireddy, SR | 1 |
1 other study(ies) available for phosphoserine and beryllium
Article | Year |
---|---|
Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium.
Topics: Beryllium; Cell Line; Cell Line, Tumor; Dose-Response Relationship, Drug; Fibroblasts; Fluorescence Resonance Energy Transfer; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Lithium Chloride; Phosphorylation; Phosphoserine; Protein Kinase Inhibitors; Real-Time Polymerase Chain Reaction; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2014 |